What is the role of serum gamma‑glutamyl transferase in predicting native liver survival after Kasai portoenterostomy in infants with biliary atresia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Role of Serum GGT in Predicting Native Liver Survival After Kasai Portoenterostomy

Serum GGT is a valuable prognostic marker for native liver survival after Kasai portoenterostomy, with specific thresholds and timing providing clinically actionable predictions: GGT >550 IU/L at 5 months post-Kasai independently predicts decreased native liver survival, while high preoperative GGT (>300 IU/L) paradoxically predicts better outcomes.

Algorithmic Approach to Using GGT for Prognostication

Preoperative Assessment

  • High preoperative GGT (>300 IU/L) predicts favorable prognosis 1
    • Sensitivity: 61.1%, Specificity: 91.1%, AUC: 0.754
    • Patients with high GGT/low ALT profiles show clearance rates exceeding 90% 2
    • This counterintuitive finding suggests that higher GGT reflects active biliary epithelial function rather than irreversible damage

Early Postoperative Period (1-3 months)

  • Monitor GGT monthly alongside total bilirubin, ALT, and platelet count 3, 4
  • At 3 months post-Kasai, elevated GGT is an independent predictor of poor 2-year native liver survival 4
    • Incorporate into nomogram with: liver fibrosis stage, APRI, age at surgery, albumin, and jaundice clearance status
    • Combined model AUC: 0.872 (training), 0.971 (validation)

Critical Decision Point: 4-5 Months Post-Kasai

  • GGT >550 IU/L at month 5 post-Kasai (Hazard Ratio: 1.74, p<0.05) 5
  • APRI >0.605 at month 4 post-Kasai (Hazard Ratio: 3.78, p=0.001) 5
  • These thresholds identify patients at significantly higher risk for liver transplantation even among those who achieved jaundice clearance

Evidence Strength and Nuances

The most recent systematic review and meta-analysis 3 (2026,4399 patients) confirms that GGT remains significantly lower in successful cases at 1-3 months and >5 years post-Kasai (p<0.001), establishing it as one of the established serum markers alongside ALT and total bilirubin.

Important Caveats

  1. Context-dependent interpretation: The prognostic value of GGT changes over time—high preoperatively is favorable, but persistently elevated postoperatively is unfavorable 2, 1, 5

  2. Not a standalone marker: GGT performs best when integrated with other parameters (APRI, albumin, total bilirubin, jaundice clearance status) 4

  3. Jaundice clearance remains paramount: Total bilirubin <2 mg/dL at 3-6 months post-Kasai remains the strongest predictor (Hazard Ratio: 5.49) 6, 5, but GGT adds prognostic value even among jaundice-free patients

  4. Age considerations: The nomogram incorporating GGT shows stable performance across age subgroups (AUC 0.926 for ≤60 days; 0.867 for >60 days) 4

Clinical Application

For transplant evaluation timing: Patients with GGT >550 IU/L at 5 months AND APRI >0.605 at 4 months should be prioritized for early transplant evaluation, even if jaundice has cleared 5. According to AASLD guidelines, at least 80% of BA patients require transplantation by age 20 years, with the majority transplanted under 4 years 6.

For resource allocation: In settings where frequent monitoring is limited, the 3-month GGT combined with albumin and APRI provides a practical checkpoint for risk stratification 4.

The evidence consistently demonstrates that GGT, when measured serially and interpreted with specific thresholds at defined timepoints, provides clinically meaningful prognostic information beyond traditional markers alone 3, 4, 2, 1, 5.

References

3
Research

Serum predictors of native liver survival post-Kasai: Systematic review and meta-analysis.

Journal of pediatric gastroenterology and nutrition, 2026

Related Questions

Can vitamin K be administered intravenously in an infant with biliary atresia?
What are the sensitivity and specificity of pale (acholic) stools for diagnosing biliary atresia?
In a patient with osteoporosis who has been on anti‑resorptive therapy for three years and now has a dual‑energy X‑ray absorptiometry (DXA) T‑score of –1.2, what is the appropriate next step in management?
What is the appropriate dose of mannitol for treating vasogenic cerebral edema?
Is daptomycin appropriate for treating cellulitis?
What does a 2‑4 kHz notch on an otherwise normal audiogram indicate?
What is the appropriate management for an uncomplicated viral cold in a one-year-old child?
What is the appropriate empiric antibiotic regimen for pneumonia in outpatient, inpatient, and ICU settings, including considerations for beta‑lactam allergy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.